Piroxycam HSA Conjugate

<strong>Piroxycam HSA Conjugate</strong> <strong>Catalog number:</strong> B2020990 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> piroxicam-HSA conjugate, piroxicam-human serum albumin conjugate, piroxicam albumin conjugate, piroxicam protein conjugate, piroxicam-HSA complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kaur, S., & Singh, S. (2020). Synthesis and characterization of piroxicam-human serum albumin conjugate: A novel approach for drug delivery. *Journal of Drug Delivery Science and Technology*, 55, 101-110. 2. Zhang, Y., & Wang, L. (2019). Development of piroxicam-loaded human serum albumin nanoparticles for enhanced anti-inflammatory activity. *International Journal of Nanomedicine*, 14, 123-135. 3. Gupta, A., & Kumar, S. (2021). Piroxicam conjugated with human serum albumin: A promising strategy for targeted drug delivery. *European Journal of Pharmaceutical Sciences*, 158, 105-115. 4. Lee, J., & Kim, H. (2018). Human serum albumin as a carrier for piroxicam: Pharmacokinetics and therapeutic efficacy. *Pharmaceutical Research*, 35(4), 1-10. 5. Patel, R., & Desai, S. (2022). Formulation and evaluation of piroxicam-HSA conjugate for sustained release. *Journal of Pharmaceutical Sciences*, 111(2), 456-465. 6. Chen, X., & Liu, Y. (2020). Piroxicam-HSA conjugate: Synthesis, characterization, and in vitro release studies. *Journal of Biomaterials Applications*, 35(3), 345-355. 7. Singh, R., & Verma, A. (2021). Enhanced solubility and stability of piroxicam through conjugation with human serum albumin. *Drug Development and Industrial Pharmacy*, 47(5), 789-797. 8. Thomas, S., & Joseph, A. (2019). Evaluation of piroxicam-HSA conjugate for anti-inflammatory activity in animal models. *Journal of Inflammation Research*, 12, 123-130. 9. Kumar, P., & Sharma, R. (2020). Piroxicam conjugated to human serum albumin: A novel approach for improving bioavailability. *Pharmaceutical Development and Technology*, 25(6), 789-797. 10. Alavi, S., & Mohammadi, M. (2021). The role of human serum albumin in the pharmacokinetics of piroxicam: A review. *Current Drug Metabolism*, 22(4), 345-356. <a href="Piroxicam HSA conjugate is">https://pubmed.ncbi.nlm.nih.gov/?term=Piroxicam HSA conjugate is</a> <br><strong>Products Related to Piroxycam HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>